期刊文献+

直肠癌淋巴结转移危险因素及预后分析 被引量:1

Analysis of lymph node metastasis risk factors and prognosis in patients with rectal cancer
下载PDF
导出
摘要 目的探讨直肠癌淋巴结转移与临床病理特征及术后生存时间之间的关系。方法分析67例行全直肠系膜切除术患者的性别、年龄、肿瘤原发灶大小、大体类型、浸润深度、组织学类型、分化程度及术前血清癌胚抗原(CEA)水平与术后淋巴结病检转移情况及与生存时间的关系。结果单因素分析结果发现,肿瘤大小、大体类型、浸润深度、组织学类型、分化程度与淋巴结转移相关;进一步多因素分析结果提示,组织学类型、分化程度与淋巴结转移相关。全组5年生存率为59.7%;无淋巴结转移组预后好于有淋巴结转移组,两生存曲线比较差异有统计学意义(χ2=13.658,P=0.000)。结论直肠癌组织学类型和分化程度是淋巴结转移的主要危险因素,根据患者临床病理特征和淋巴结转移之间的相关性能够更准确诊断病情、制定治疗方案以及判断预后。 Objective To investigate the correlation between lymph node metastasis and clinical factors, prognosis in rectal cancer. Methods Collected the statistics of 79 cases who accepted total mesorectal excision( TEM), such as clinical factors, prognosis and lymph node metastasis. And analyzed the correlation between the third and the preceding two factors. Results There was significant correlation between five factors ( namely the tumor size, massive type, depth of invasion, histology type and differentiating degree ) and lymph node metastasis in monovariate analysis. However only two factors-histology type and differentiating degree-were left in multivariate analysis. The 5-year survival rate of total group was 59.7%. The prognosis of nolymph metastasis group was statistically better than that of the group with metastasis (χ^2 = 13. 658, P = 0. 000). Conclusion Histology type and differentiating degree are main risk factors of lymph node metastasis in rectal cancer. Doc- tor can more accurately diagnose, make therapeutic regimen and judge prognosis of patients with rectal cancer according to the correlation between lymph node metastasis and elinicopathologic factors.
出处 《中国实用医药》 2008年第34期48-50,共3页 China Practical Medicine
关键词 直肠癌 淋巴结转移 预后分析 临床治疗 Rectal cancer Lymph node metastasis
  • 相关文献

参考文献12

  • 1[1]Stecchi L,Nelson H,Sargent D J,et al.Impact of surgical and pathologic variables in rectal cancer:a United States community and cooperative group report.J Clin Oncol,2001,19(18):3895-3902.
  • 2[2]lshikawa Y,Akishima-fukasama Y,Ito K,et al.Histopathologic determinants of regional lymph node metastasis in early colorectal cancer.Cancer,2008,112 (2):924.
  • 3[3]Iwashita A.Pathomorphologic study comceming risk factor of lymph node metastasis colorectal submucosal invaslve(sm) carcinomas of Is type.Stomach & Intestine(Tokyo),1997,32 (11):1511-1520.
  • 4[4]Bayar S,Saxcna R,Emir B,et al.Venous invasion may predict lymph node metastasis in early rectal cancer.Eur J Surg Oncol,2002,28(4):413.
  • 5[5]Kobayashi M,Watanabe H,Maeo S,et al.Correlation of histological atypia and cancer-sprouting with vascular permeation and lymph nodal metastasis by our new histological classification of submucosal invasion by colorectal carcinomas.Stomach & Intestine,1994,29 (11):1151-1160.
  • 6[6]Suzuki T,Sadahiro S,Mukoyama S,et al.Risk of lymph node and distant metastasis in patients with early invasive coiorectal cancer classified as Haggitt,s level 4 invasion:image analysis of submucosal layer invasion.Dis Colon Rectum,2003,46 (2):203.
  • 7[7]Heald RJ,Moran BJ,Ryall RD,et al.Rectal cancer:the Basingstoke experience of total mesorectal excision,1978-1997.Arch Surg,1998,133(8):894.
  • 8[8]Roncucci L,Fante R,Lesi L,et al.Survival for colon and rectal cancer in a population-based cancer registry.Eur J Cancer,1996,32 (2):295.
  • 9[9]Elsaleh H,Csemi G,Iacopottu B.Extent of involvement in stage Ⅲ colorectal carcinoma:relationship to clinicopathologic variables and genetic alterations.Dis Colon Rectum,2002,45(9):1218.
  • 10[10]Arbman G,Nilsson E,Hallbook O,et al.Local recurrence following total mesorectal excision for rectal cancer.Br J Surg,1996,83 (3):375-379.

二级参考文献11

  • 1卿三华.影响结直肠癌预后的临床和病理危险因素[J].中华胃肠外科杂志,2004,7(6):434-435. 被引量:11
  • 2梁寒,郝希山,王仆,王晓娜,李景武,王家仓,王殿昌.影响直肠癌患者术后生存的多因素Cox回归分析[J].中华肿瘤杂志,2004,26(11):688-691. 被引量:18
  • 3余丹,李铁钢,姚宏亮,赵华,刘国清,皮执民.直肠癌淋巴结转移相关因素的临床探讨[J].中南大学学报(医学版),2006,31(1):128-130. 被引量:6
  • 4徐建明.结直肠癌的辅助和新辅助治疗[J].临床肿瘤学杂志,2007,12(8):561-565. 被引量:9
  • 5Nash GM, Saltzl B , Kemeny NE, et al . Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage Ⅳ disease Annals. Surg Oncol, 2002,9(10):954
  • 6Chau I, Cunningham B. Chemotherapy in colorectal cancer:new potions and new chanllenges. Br Med Bull, 2002,64(1):159
  • 7Benson AB, Schrag D, Somerfield MR, et al. American Society of Clinical Ontology recomma endations on adjuvant chemotherapy for stage Ⅱ colon cancer. J Clin Oncol, 2004, 22(16):3408
  • 8Park J, Youk EG, Choi HS, et al. Experience of 1446 rectal cancer patients in Korea and analysis of prognosis factors.Int J Colorect Dis, 1999,14(2):101
  • 9Park YJ, Park KJ, Park JG, et al. Prognostic factors in 2230 Korean colorectal cancer patients: analysis of consecutively operated cases.World J Surg, 1999,23(7) :721
  • 10Wong JH, Steinemann S, Tom P, et al. Volume of lymphatic metastases does not independently influence prognosis in colorectal cancer. J Clin Oncol, 2002, 20(6):1506

共引文献27

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部